More? than 40? anti-angiogenic agents? are being studied? in clinical trials in the United States, Europe, and Australia. Some are being studied in combination with more? traditional therapies, like chemotherapy, while others are being? studied alone or with other targeted treatments.? Researchers? are looking at the? use of? these anti-angiogenic agents in? many types of cancer, such as brain, breast, lung, ovarian, pancreatic and prostate.?

To find a? study location? in your area, please visit www.CancerTrialsHelp.org.

---

Learn more at: www.newfrontierincancer.org

Sponsored by Genentech BioOncology, in partnership with the Cancer Research and Prevention Foundation and the Coalition of Cancer Cooperative Groups.